Leah Buletti

Patients showed few side effects and strong outcomes, which has led to changes in treatment guidelines.

UF Health is an early adopter of a new radiopharmaceutical technology. When Steve became eligible, he decided to give it a chance.

Sylvester Comprehensive Cancer Center is leading a groundbreaking initiative designed to transform survivorship care in community health centers across South Florida.

A potential treatment for glioblastoma has received approval from the FDA to move to clinical trials.

Cancer-hunting antibodies coupled with a natural compound proved a powerful combination against lymphoma.

A new drug tested at Sylvester Comprehensive Cancer Center is generating encouraging results for patients with low-grade gliomas.

Mayo Clinic is bringing new hope for patients diagnosed with the most aggressive and treatment-resistant cancers.

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data from the ADVANCE clinical trial.

The pioneering work at Sylvester is bringing hope to patients at a time when melanoma cases are on the rise.

After more than a decade of cancer treatment at UF Health, Dave felt supported every step of the way.